About Gnosis Pharmaceutical
Gnosis Pharmaceutical is a company based in Delhi (India) founded in 2007. It operates as a B2B and B2C. The company has 309 employees as of March 31, 2024. Gnosis Pharmaceutical offers products and services including Kainosis Tablets, Intel Syrup, Cygnus Capsules, and Tycoon Cream. Gnosis Pharmaceutical operates in a competitive market with competitors including Enzene Biosciences, Hybio Pharmaceutical, Suanfarma, Nephron Pharmaceuticals and AmbioPharm, among others.
- Headquarter Delhi, India
- Employees 309 as on 31 Mar, 2024
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Gnosis Pharmaceuticals Private Limited
- Date of Incorporation 17 Mar, 2005
- Jurisdiction New Delhi, Delhi, India
-
Annual Revenue
$10.37 M (USD)18.21as on Mar 31, 2024
-
Net Profit
$125.62 K (USD)143.33as on Mar 31, 2024
-
EBITDA
$732.9 K (USD)34.63as on Mar 31, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
309
as on Mar 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Gnosis Pharmaceutical
Gnosis Pharmaceutical offers a comprehensive portfolio of products and services, including Kainosis Tablets, Intel Syrup, Cygnus Capsules, and Tycoon Cream.
Tablets for general health and treatment purposes.
Syrups designed for various medical conditions.
Capsules providing essential health benefits.
Creams for skin care and topical applications.
Funding Insights of Gnosis Pharmaceutical
Detailed funding history for Gnosis Pharmaceutical
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Gnosis Pharmaceutical
Investment portfolio details for Gnosis Pharmaceutical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Gnosis Pharmaceutical
Detailed financials for Gnosis Pharmaceutical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Gnosis Pharmaceutical Comparisons
Peer comparison for Gnosis Pharmaceutical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Gnosis Pharmaceutical
Gnosis Pharmaceutical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Enzene Biosciences, Hybio Pharmaceutical, Suanfarma, Nephron Pharmaceuticals and AmbioPharm, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Company specializing in development of Biosimilars
|
|
| Locked | Locked | Locked |
Polypeptide drugs and APIs are developed and manufactured.
|
|
| Locked | Locked | Locked |
Generics, nutraceuticals, and APIs are developed by Suanfarma.
|
|
| Locked | Locked | Locked |
Sterile pharmaceutical products are manufactured and contract services are provided.
|
|
| Locked | Locked | Locked |
CDMO and analytical services for peptide development are provided.
|
|
| Locked | Locked | Locked |
APIs and finished dosage forms are developed and manufactured.
|
Detailed competitors of Gnosis Pharmaceutical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Gnosis Pharmaceutical
Complete news archive for Gnosis Pharmaceutical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gnosis Pharmaceutical
Gnosis Pharmaceutical was founded in 2007.
Gnosis Pharmaceutical is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
As of Mar 31, 2024, the latest employee count at Gnosis Pharmaceutical is 309.
Annual revenue of Gnosis Pharmaceutical is $10.37M as on Mar 31, 2024.
Gnosis Pharmaceuticals Pvt. Ltd. produces a range of pharmaceutical products such as tablets, capsules, syrups, and creams through its divisions like Kainosis and Intel. The company operates from locations in Delhi, Chandigarh, and Himachal Pradesh, focusing on quality manufacturing and contract services. It serves domestic and export markets with innovative healthcare solutions, emphasizing research and global standards.
Gnosis Pharmaceutical's top competitors include Nephron Pharmaceuticals, Suanfarma and Enzene Biosciences.
Gnosis Pharmaceutical offers Kainosis Tablets, Intel Syrup, Cygnus Capsules, and Tycoon Cream.